PI3K-IN-33
Modify Date: 2024-01-10 17:02:51
PI3K-IN-33 structure
|
Common Name | PI3K-IN-33 | ||
|---|---|---|---|---|
| CAS Number | 2458163-92-1 | Molecular Weight | 493.36 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H21BrN6O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PI3K-IN-33PI3K-IN-33 (Compound 6e) is a highly selective PI3K inhibitor with IC50 values of 11.73, 6.09 and 11.18 μM for PI3K-α、PI3K-β and PI3K-δ , respectively. PI3K-IN-33 arrests cell cycle at G2/M phase and induces apoptosis. PI3K-IN-33 can be used in leukemia research[1]. |
| Name | PI3K-IN-33 |
|---|
| Description | PI3K-IN-33 (Compound 6e) is a highly selective PI3K inhibitor with IC50 values of 11.73, 6.09 and 11.18 μM for PI3K-α、PI3K-β and PI3K-δ , respectively. PI3K-IN-33 arrests cell cycle at G2/M phase and induces apoptosis. PI3K-IN-33 can be used in leukemia research[1]. |
|---|---|
| Related Catalog | |
| Target |
PI3Kα:11.73 μM (IC50) PI3Kβ:6.09 μM (IC50) PI3Kδ:11.18 μM (IC50) |
| In Vitro | PI3K-IN-33 (Compound 6e) (10 μM, 48 hours) possess potent antiproliferative activity can inhibit proliferation of Leukemia SR cell lines in vitro[1]. PI3K-IN-33 (Compound 6e) induces cell cycle arrest toward the G2-M phase (30.3%) and leads to DNA synthesis and apoptosis[1]. PI3K-IN-33 (Compound 6e) (10 μM, 48 hours) results in apoptotic with 12.13% of cells in the early and latest age[1]. Cell Cytotoxicity Assay[1] Cell Line: Leukemia SR cell lines. Concentration: 10 μM Incubation Time: 48 hours Result: Antiproliferative activity with values of 0.76 μM. |
| References |
| Molecular Formula | C23H21BrN6O2 |
|---|---|
| Molecular Weight | 493.36 |